| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/05/2009 | CN101496917A Serum preparation equipment for cell culture as well as serum preparation method and cell culture method |
| 08/05/2009 | CN101496871A Chinese medicinal composition with functions for tonifying blood and improving sleep as well as preparation method thereof |
| 08/05/2009 | CN101496851A Chinese medicine for treating carcinous pleural fluid and ascites |
| 08/05/2009 | CN101496797A Salvianolic acid A phospholipid complexes and preparation method thereof |
| 08/05/2009 | CN101496787A Prostaglandin E1 lipid microsphere injection with charge effect and preparation method thereof |
| 08/05/2009 | CN101496636A Method for preparing and using functional plant stuffing for thin sheet raw material of paper-making process |
| 08/05/2009 | CN100523185C Agkistrodonacutus thrombin preparation method and uses |
| 08/05/2009 | CN100522995C Cell wall acyl-alanyl-D-isoglutamine derivative and its preparation, medicine composition and use |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/05/2009 | CN100522232C Pharmaceutical composition and usage |
| 08/05/2009 | CN100522190C Method for extracting total saponin for Chinese herb medicine clinopodium polycephalum |
| 08/05/2009 | CN100522188C New use and preparation of smoke tree extract for Chinese medicine |
| 08/05/2009 | CN100522140C Preparation and application of dragon blood medicinal composition |
| 08/05/2009 | CN100522139C 'Mailuoning' injection and preparation method |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | CA2506081C Water-soluble mesoporphyrin compounds and methods of preparation |
| 08/04/2009 | CA2457996C Medicinal preparation containing phenylethanoid glycosides extracted from herbaceous plant, cistanche tubulosa (schenk.) wight, process of making the same, and uses of the same |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2347447C Buffered compositions for dialysis |
| 07/30/2009 | WO2009094551A1 Ferroportin antibodies and methods of use |
| 07/30/2009 | WO2009094456A2 Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection |
| 07/30/2009 | WO2009093972A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 07/30/2009 | WO2009093534A1 Vegfc production promoter |
| 07/30/2009 | WO2009093138A1 Humanized antibodies specific for von willebrand factor |
| 07/30/2009 | WO2009092276A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
| 07/30/2009 | WO2008134445A8 Platelet activation receptor clec-2: compositions and uses thereof |
| 07/30/2009 | WO2008128149A3 Providing hemostasis in anticoagulated blood by using zeolites |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192175 Insecticidal compounds |
| 07/30/2009 | US20090192137 Dialysis method |
| 07/30/2009 | US20090192123 Optionally in combination with antithrombotic agents, ACE inhibitor, Angiotensin antagonist, Calcium antagonist, statins, or antidiabetic agents |
| 07/30/2009 | US20090192081 Casein derived peptides and uses thereof |
| 07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
| 07/30/2009 | US20090191223 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 07/30/2009 | US20090191179 Use of factor VIIa analogues with increased activity |
| 07/30/2009 | US20090191177 Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)ethylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026 |
| 07/30/2009 | DE102007057718A1 New heteroaryl-substituted piperidine compounds are protease-activated receptor antagonists useful for the treatment and/or prophylaxis of e.g. cardiovascular diseases, thromboembolic diseases, tumors, stroke, hypertension and asthma |
| 07/30/2009 | CA2712221A1 Humanized antibodies specific for von willebrand factor |
| 07/30/2009 | CA2711826A1 Ferroportin antibodies and methods of use |
| 07/30/2009 | CA2711535A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
| 07/29/2009 | EP2081964A2 Alginate and alginate lyase compositions and methods of use |
| 07/29/2009 | EP2081589A2 Complementation of factor xi deficiency by factor v mutants |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN100518820C A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 07/29/2009 | CN100518817C Therapeutic agent to recover hematopoiesis function and its compositions and usage |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566722 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists |
| 07/28/2009 | US7566713 Immuno inhibitory heterocyclic compounds |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/28/2009 | US7566699 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/28/2009 | CA2435159C A method of preparing a collagen sponge |
| 07/28/2009 | CA2354574C Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same |
| 07/23/2009 | WO2009071690A3 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 07/23/2009 | WO2009071689A3 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 07/23/2009 | WO2009063499A3 A herbomineral formulation for treating sickle cell disease |
| 07/23/2009 | WO2009061889A3 Grape polyphenolics for platelet and bacterial control |
| 07/23/2009 | US20090187013 Synthetic heparin pentasaccharides |
| 07/23/2009 | US20090186921 Azacyclic compounds |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186876 Pyridine Analogues II |
| 07/23/2009 | US20090186851 Hemostatic material |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | US20090186822 Thrombopoietic Compounds |
| 07/23/2009 | US20090186804 Anticoagulant and composition for preventing thrombus containing poly-gamma-glutamic acid |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186013 Inorganic materials for hemostatic modulation and therapeutic wound healing |
| 07/23/2009 | DE102008005469A1 Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung Pasty Einsetzmaterial widening the gingival sulcus and its use |
| 07/23/2009 | DE102008004920A1 Blood soluble, flow resistance reducing composition, useful e.g. to increase arterial blood flow, capillary blood flow and peripheral vascular resistance, comprises hydroxyethyl amylose and further hydroxyethyl starch in a carrier solution |
| 07/22/2009 | EP2080759A1 Gama-globin inducer |
| 07/22/2009 | EP2080751A1 Carboxylic acid derivative |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2079711A2 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 07/22/2009 | EP2079464A2 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor |
| 07/22/2009 | EP1750704B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1453528B1 Compositions containing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1299354B1 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 07/22/2009 | EP1115390B1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/21/2009 | US7563872 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563782 Optically active stereoisomer of efonidipine analogs; R-configuration of the 4-position on dihydropyridine ring; kidney insufficiency; hypercardia; congestive heart failure; cardiomyopathy; arterial sclerosis; antifibrillatory/antiarrhythmia agents; cardiovascular disorders; antiedemic/antiinflammatory |
| 07/21/2009 | US7563780 Heparin prodrugs and drug delivery stents formed therefrom |
| 07/21/2009 | CA2478393C 1-allyl ergot alkaloid derivatives, methods for their production and their use for migraine prevention and treatment |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2387486C Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089035A1 Methods and systems for expanding ac133+ cells and directing differentiation |
| 07/16/2009 | WO2009088530A1 Pterin analog for treating bh4 responsive condition |
| 07/16/2009 | WO2009088063A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |